A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Lentivirus Production

67.5K views

DOI:

10.3791/1499

October 2nd, 2009

 , 

Corresponding Authors: Michael McManus <mmcmanus@diabetes.ucsf.edu>

In This Article

Summary

To make lentiviruses, DNA vectors are transfected into human 293 cells. After harvest and concentrating the supernatant, virus titer is determined by fluorescence expression with a flow cytometer.

Abstract

RNA interference (RNAi) is a system of gene silencing in living cells. In RNAi, genes homologous in sequence to short interfering RNAs (siRNA) are silenced at the post-transcriptional state. Short hairpin RNAs, precursors to siRNA, can be expressed using lentivirus, allowing for RNAi in a variety of cell types. Lentiviruses, such as the Human Immunodeficiency Virus, are capable to infecting both dividing and non-dividing cells. We will describe a procedure which to package lentiviruses. Packaging refers to the preparation of competent virus from DNA vectors. Lentiviral vector production systems are based on a 'split' system, where the natural viral genome has been split into individual helper plasmid constructs. This splitting of the different viral elements into four separate vectors diminishes the risk of creating a replication-capable virus by adventitious recombination of the lentiviral genome. Here, a vector containing the shRNA of interest and three packaging vectors (p-VSVG, pRSV, pMDL) are transiently transfected into human 293 cells. After at least a 48-hour incubation period, the virus containing supernatant is harvested and concentrated. Finally, virus titer is determined by reporter (fluorescent) expression with a flow cytometer.

Protocol

Part 1: Transfection of HEK 293 Cells To Produce Lentiviruses

*24 hours before transfection, plate 2.5 X 106 cells in a 10cm dish for a confluency of 50-70% the next day.

  1. Start this protocol by preparing the DNA with which one will later transfect one's cells to make virus. First, dilute FuGENE 6 Transfection Reagent Roche, a lipid reagent that make cells take up DNA. In a 1.5 ml tube, pipette 30μl FuGENE 6 into 600ul serum-free medium (SFDMEM). Be careful to not let FuGENE touch the side of the tube as it is delivered into the medium. Let this FuGENE and SFDMEM mix and incubate at room temperature for 5 minutes.

Access restricted. Please log in or start a trial to view this content.

Acknowledgements

Sandler Asthma Basic Research Center (SABRE)
Sandler Foundation

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
DMEM HEK 293T cells Penicillin-streptomycin Glutamine Phosphate-buffered saline FBSInvitrogen
FuGENE 6 transfection reagent pSico mCherry pMDL pRSV pVSVGRoche Group
BleachClorox
10-cm cell culture dishes 96 well cell culture dishes Falcon BD353003
Multichannel pipetteRainin
Filtered pipette tipsRainin
1.5ml Eppendorf tubes Syringe Syinge filter (0.45-μm)Eppendorf
Ultracentrifuge tubesBeckman Coulter Inc.
Tissue culture incubator at 5% CO2Coulter
Beckman SW41T.I rotor
Beckman ultracentrifugeBeckman Coulter Inc.
Fluorescent microscopeCoulter
FACS ArrayBeckman Coulter Inc.

References

  1. Reiser, J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Therapy. , 72-7211 (2000).
  2. Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., Naldini, L. J Virol. 72 (11), 8463-8471 (1998).
....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Viral TiterFlow CytometryUltracentrifugationTransfectionPlasmid DNAViral PackagingSerial DilutionFluorescent ReporterBiosafety Regulations